Dr. Peter Quiros joins host Dr. Amanda Redfern to discuss the recent JAMA Ophthalmology article "The Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide," the first study to report a possible association between semaglutide (Wegovy, Ozempic, Novo Nordisk) and nonarteritic anterior ischemic optic neuropathy (NAION). Dr. Quiros provides an overview of what the study showed and what remains unknown, and how ophthalmologists should discuss these recent findings with their patients.

Check out the Semaglutide and NAION patient brochure, courtesy of the North American Neuro-Ophthalmology Society (NANOS), and available from www.nanosweb.org.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör American Academy of Ophthalmology. Innehållet i podden är skapat av American Academy of Ophthalmology och inte av, eller tillsammans med, Poddtoppen.